Pomerantz Law Firm Files Class Action Against Chemours Over Opteon Claims
6 days ago
Pomerantz LLP filed a class action lawsuit against Chemours, alleging misleading statements regarding Opteon product demand and fiscal 2026 guidance. The suit claims these misrepresentations caused significant stock price declines following Q2 financial results.